
CJC-1295 No DAC
$85.00
Modified GRF(1–29) GHRH analog without DAC, studied for short-acting GHRH receptor signaling.
- Purity
- >99%
- Testing
- 3rd-party
- Shipping
- Tracked, discreet
Need the Certificate of Analysis for this batch? Request a COA.
About CJC-1295 No DAC
Physiological GHRH pulsatility. Short-acting growth hormone axis research. CJC-1295 No DAC, also known as Modified GRF 1-29, is a synthetic analog of the first 29 amino acids of endogenous Growth Hormone-Releasing Hormone (GHRH), incorporating four amino acid substitutions to improve stability and receptor affinity relative to native GHRH 1-29. Unlike CJC-1295 with DAC, this formulation does not incorporate Drug Affinity Complex technology and therefore does not bind albumin, resulting in a shorter half-life that more closely mirrors the pulsatile pattern of endogenous GHRH secretion. This physiological pulsatility profile makes CJC-1295 No DAC a widely used research compound for studying natural GH axis dynamics. Research Applications:
- Pulsatile GHRH receptor agonism and physiological GH secretion pattern research
- Short-acting GH axis stimulation and pituitary somatotroph activation studies
- Comparative pharmacokinetics of DAC versus non-DAC GHRH analog formulations
- IGF-1 axis modulation and downstream anabolic signaling pathway research
- GH pulse amplitude and frequency regulation in preclinical models



